checkAd

     108  0 Kommentare Merck Begins Tender Offer to Acquire Acceleron Pharma Inc. - Seite 4

    The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except to the extent required by law. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the SEC available at the SEC’s Internet site (www.sec.gov).

    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen
    Seite 4 von 4

    Merck Begins Tender Offer to Acquire Acceleron Pharma Inc. - Seite 4 Merck (NYSE: MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Acceleron Pharma Inc. (Nasdaq: XLRN). On Sept. 30, 2021, Merck …

    Schreibe Deinen Kommentar

    Disclaimer